Remus Pharmaceuticals dividend 2025

REMUS

700

30.05 (-4.12%)
Last updated on 7 Oct, 2025 | 15:28 IST
BUYSELL

The current prices are delayed, login to your account for live prices

Remus Pharmaceuticals Dividend Details

Record Date

18-Sep-2025

Ex Date

18-Sep-2025

Dividend Type

Equity Share

Dividend Per Share

5.00

Remus Pharmaceuticals Dividend History

Record DateDividend Per ShareDividend TypeEx-Date
18-Sep-20250.05Equity Share18-Sep-2025
20-Nov-20240.10Equity Share19-Nov-2024
02-May-20240.40Equity Share02-May-2024

Upcoming Dividends by Indian Companies

View More
CompanyDividends RatioAnnouncementRecord DateDividends Date
LTIMindtree Ltd.001-Oct-202524-Oct-202524-Oct-2025
ICICI Lombard General Insurance Company Ltd.025-Sep-202523-Oct-202523-Oct-2025
Tata Consultancy Services Ltd.022-Sep-202515-Oct-202515-Oct-2025
Rashtriya Chemicals and Fertilizers Ltd.0.13227-May-202510-Oct-202510-Oct-2025
Hexaware Technologies Ltd.5.7501-Oct-202510-Oct-202510-Oct-2025

Remus Pharmaceuticals Dividend FAQs

The latest dividend declared by Remus Pharmaceuticals is of 0.05 per share for the financial year as announced on 18-Sep-2025.

Registered shareholders who own Remus Pharmaceuticals’s shares on or before the record date of 18-Sep-2025 set by the company are eligible to receive the dividend. You will not be entitled to the payout if you purchase shares on or after the ex-dividend date of 18-Sep-2025.

You can expect to receive Remus Pharmaceuticals’s dividend in your bank account linked to your Demat account within 25 to 45 business days after the record date of 18-Sep-2025. The record date is when Remus Pharmaceuticals identifies eligible shareholders for the dividend payment.

The annual dividend paid by Remus Pharmaceuticals varies according to its financial performance and dividend policy. Generally, companies in different sectors exhibit varying dividend yields. To determine Remus Pharmaceuticals's specific annual dividend, it’s advisable to consult the company's official investor relations website or recent financial statements.